Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH)

Award Number: UG1CA284884
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 08/15/2023
PERIOD OF PERFORMANCE END DATE: 05/31/2027

Group Awards By:

View Award Description

Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH) - Women living with HIV (WLWH) have a substantially increased risk for cervical cancer compared to women without HIV infection. Georgia has one of the largest populations of people living with HIV in the U.S., with a significantly higher prevalence than the national average. Concurrently, Georgia’s rates of cervical cancer exceed national levels. Georgia is therefore a critical location for conducting pragmatic clinical trials aimed at improving cervical cancer screening and treatment for WLWH. The Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC) brings together established, well-funded programs across Georgia that serve WLWH and are well positioned to lead the ‘CASCADE’ Network clinical trials. Consortium members include Emory University’s HIV research and clinical networks, urban and rural Ryan White-funded clinics, Morehouse School of Medicine’s community networks, the Georgia Cancer Center for Excellence at Grady Health System, and other key HIV and women’s health organizations in the state. The GaCECC clinical sites collectively served over 9,000 WLWH and performed more than 5,000 cervical cancer screenings between 2020 and 2021 in both urban and rural areas. The GaCECC’s client navigation team will support participant access to and completion of screening and treatment. The recruitment and retention team will coordinate care from community clinics to colposcopy at the central treatment site. Grady Memorial Hospital’s Mobile Health Center Vehicle will deliver colposcopy services to women who cannot travel. Emory University, Morehouse School of Medicine, and AAPHC-affiliated gynecologists will provide protocol-based treatment at various clinical sites. The consortium’s experienced investigators and research staff will ensure high-quality implementation of clinical trial protocols and strong participant retention. The GaCECC will leverage the collective strengths of its partners to advance cervical cancer prevention for WLWH. In summary, the GaCECC will (Aim 1) apply its leadership in HIV care and cervical cancer prevention, (Aim 2) conduct research through the ‘CASCADE’ Network clinical trial, and (Aim 3) implement pragmatic clinical trials in cervical cancer prevention across all scientific focus areas, utilizing its community-based partnerships to support enrollment and retention of WLWH.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Cancer Control	000	3	1/9/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $519,320 )
2025	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Cancer Control	001	3	9/3/2025	NON-COMPETING CONTINUATION	$519,320
2025	2024	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Cancer Control	000	2	4/16/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $519,320

Issue Date FY: 2024 ( Subtotal = $313,858 )
2024	2024	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Cancer Control	002	2	7/1/2024	NON-COMPETING CONTINUATION	$0
2024	2024	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Cancer Control	001	2	6/3/2024	NON-COMPETING CONTINUATION	$313,858
2024	2023	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	Cancer Control	000	1	10/16/2023	NEW	$0
														Subtotal = $313,858

Issue Date FY: 2023 ( Subtotal = $324,621 )
2023	2023	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	Cancer Control	001	1	8/15/2023	NEW	$0
2023	2023	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	Cancer Control	000	1	8/10/2023	NEW	$324,621
														Subtotal = $324,621

Grand Total All Awards = $1,157,799

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH)

Award Number: UG1CA284884

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 08/15/2023

PERIOD OF PERFORMANCE END DATE: 05/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer